Skip to main content
Premium Trial:

Request an Annual Quote

Ben Ho Park

Vanderbilt has announced that Ben Ho Park has been named co-leader of the breast cancer research program, director of the precision oncology, and associate director for translational research at the Vanderbilt-Ingram Cancer Center. Park, who will assume the post Sept. 1, succeeds Carlos Arteaga. Park currently serves as professor of oncology in the bresat and ovarian cancer program, associate director for research training and education, and member of the executive oversight committee at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University. Park received his undergraduate degree from the University of Chicago, followed by dual training at the University of Pennsylvania School of Medicine. 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.